Allosteric modulators for
human health
About us
Addex Corporate Presentation
Overview
Our people
Executive Officers
Non-Executive Directors
Contact
Privacy Policy
Careers
Pipeline
Clinical and Pre-Clinical Pipeline
Research And Development
Technology
Allosteric modulation
Publications
Partners & collaboration
Investors
Addex corporate Presentation
Stock Data
Press releases
Ad hoc announcements (Art. 53 L.R)
Events
Financial Reports
Analyst Reports
General Meetings
SEC / SIX Filings
Guide to US ADSS for Six Shareholders
Register for email news
Corporate Governance
Contact
Media
Press releases
Contact
Press releases
All Years
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
Please select year
11.15
2021
Addex to Present at the H.C. Wainwright 7th Annual Israel Virtual Conference
11.04
2021
Addex Reports Q3 2021 Financial Results and Provides Corporate Update
11.01
2021
Addex Therapeutics to Release Q3 2021 Financial Results and Host Conference Call on November 4, 2021
10.06
2021
Addex to Present at the Investors’ Day hosted by Voxia Communication
10.04
2021
Addex to Present at the 10th International Meeting on Metabotropic Glutamate Receptors
09.29
2021
Addex Therapeutics Initiates Phase 2 Clinical Study with Dipraglurant in Blepharospasm
09.29
2021
Addex to Present at the Cantor Global Healthcare 2021 Conference
09.22
2021
CMTA and Addex Therapeutics Enter Collaboration to Advance GABA B PAM as Potential Treatment for CMT1A
09.08
2021
Addex to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
09.02
2021
Addex to Present at the Swiss Biotech Day
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
Next
Back